DK0784475T3 - Prostaglandinanaloger til oral eller vaginal indgivelse til rutinemæssig behandling af fødslens tredje trin - Google Patents

Prostaglandinanaloger til oral eller vaginal indgivelse til rutinemæssig behandling af fødslens tredje trin

Info

Publication number
DK0784475T3
DK0784475T3 DK95932120T DK95932120T DK0784475T3 DK 0784475 T3 DK0784475 T3 DK 0784475T3 DK 95932120 T DK95932120 T DK 95932120T DK 95932120 T DK95932120 T DK 95932120T DK 0784475 T3 DK0784475 T3 DK 0784475T3
Authority
DK
Denmark
Prior art keywords
stage
birth
oral
vaginal administration
prostaglandin analogues
Prior art date
Application number
DK95932120T
Other languages
English (en)
Inventor
Hazem A El-Refaey
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Application granted granted Critical
Publication of DK0784475T3 publication Critical patent/DK0784475T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
DK95932120T 1994-09-27 1995-09-26 Prostaglandinanaloger til oral eller vaginal indgivelse til rutinemæssig behandling af fødslens tredje trin DK0784475T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9419566A GB9419566D0 (en) 1994-09-27 1994-09-27 Oral prostagladins for the routine management of the third stage of labour
PCT/GB1995/002277 WO1996009825A1 (en) 1994-09-27 1995-09-26 Prostagladin analogues by the oral or vaginal route for the routine management of the third stage of labour

Publications (1)

Publication Number Publication Date
DK0784475T3 true DK0784475T3 (da) 2001-04-02

Family

ID=10762026

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95932120T DK0784475T3 (da) 1994-09-27 1995-09-26 Prostaglandinanaloger til oral eller vaginal indgivelse til rutinemæssig behandling af fødslens tredje trin

Country Status (11)

Country Link
US (1) US6664290B1 (da)
EP (1) EP0784475B1 (da)
AT (1) ATE198707T1 (da)
AU (1) AU3530095A (da)
DE (1) DE69519933T2 (da)
DK (1) DK0784475T3 (da)
ES (1) ES2154348T3 (da)
GB (1) GB9419566D0 (da)
GR (1) GR3035389T3 (da)
PT (1) PT784475E (da)
WO (1) WO1996009825A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1003199B (el) 1998-08-14 1999-09-01 Χρηση της μισοπροστολης ή και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση της σεξουαλικης δυσλειτουργιας στις γυναικες
EP1128858A1 (en) 1998-11-13 2001-09-05 Elan Pharma International Limited Drug delivery systems and methods
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) * 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
WO2006133048A2 (en) * 2005-06-03 2006-12-14 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same
WO2007035954A2 (en) * 2005-09-23 2007-03-29 Duramed Pharmaceuticals, Inc. Vaginal tablets comprising misoprostol and methods of making and using the same
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
CN102580057B (zh) * 2012-03-14 2014-04-30 南京先宇科技有限公司 含有麦角新碱与缩宫素类似物的药物组合物及制备方法
CN103340837B (zh) * 2013-07-08 2018-04-27 天津市聚星康华医药科技有限公司 一种米索前列醇阴道泡腾片及其制备方法
US20160008310A1 (en) 2014-07-11 2016-01-14 Azanta A/S Misoprostol dispersible tablet
WO2016004960A2 (en) * 2014-07-11 2016-01-14 Azanta A/S Misoprostol dispersible tablet

Also Published As

Publication number Publication date
AU3530095A (en) 1996-04-19
DE69519933T2 (de) 2001-09-06
DE69519933D1 (de) 2001-02-22
PT784475E (pt) 2001-06-29
WO1996009825A1 (en) 1996-04-04
GB9419566D0 (en) 1994-11-16
ES2154348T3 (es) 2001-04-01
EP0784475B1 (en) 2001-01-17
EP0784475A1 (en) 1997-07-23
GR3035389T3 (en) 2001-05-31
US6664290B1 (en) 2003-12-16
ATE198707T1 (de) 2001-02-15

Similar Documents

Publication Publication Date Title
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
ATE319474T1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
DE3854741D1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
ATE241361T1 (de) Mittel zur hormonalen kontrazeption
DE59510626D1 (de) Verwendung von kompetitiven progesteronantagonisten für die herstellung von arzneimitteln zur behandlung von dysfunktionellen uterinen blutungen
NO990934L (no) Anvendelse av arakidonsyre og/eller dokosaheksansyre for fremstilling av et medikament for behandling av dyspraksi
ATE198707T1 (de) Prostaglandinanaloga zur oralen oder vaginalen verabreichung in der routinebehandlung des dritten stadiums der geburtswehen
PT998287E (pt) Utilizacao de levobupivacaina
ATE451123T1 (de) Vaginal verabreichbare zusammensetzung zur behandlung von uteriner dysrhythmie
DE3873855D1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
RU2148988C1 (ru) Усовершенствованная лекарственная форма человеческого интерферона-свеча
SE9003904D0 (sv) Method for the manufacture of a pharmaceutical dosage form
ATE220912T1 (de) Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung
ATE290384T1 (de) Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen
ES8206473A1 (es) Procedimiento para la preparacion de derivados de prostaci- clina
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
EP0093497A3 (en) Anthelmintic treatment
DE69428797D1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
HUP9800623A2 (hu) (+)-O-demetil-tramadol felhasználása fájdalomcsillapító hatású orális gyógyszerkészítmények előállítására
RU94045125A (ru) Способ лечения рака матки и яичников
SU1424807A1 (ru) Способ определени показаний к хирургическому лечению внутреннего эндометриоза матки
Cushner The current status of the use of prostaglandins in induced abortion.
Iranpour Application of enamel adhesives in oral surgery
DE68901018D1 (de) Arzneimittel zur regulierung der hormonellen sekretionen und zur behandlung der weiblichen sterilitaet.